MGC Signs Agreement for Construction of GMP Pharma Facility
Filed with ASX · · 4 pages · English
Earlier from Argent Biopharma
- Additional Information on Ground-breaking Research
- MGC Research- Effectiveness of Cannabinoids on Brain Cancers
- Germany, Austria & Switzerland Distribution Agreement Signed
- Brazil Distribution Agreement signed for MGC Pharma Products
- Pharma Update - Increased Orders and Clinical Study
Later from Argent Biopharma
- MXC 100 Patient Milestone in Aus, Onboards Tetra Health
- Canaccord to Lead LSE Listing and $4.75m Placement Closed
- Trial on the Effect of CannEpil on Driver Competency
- Approval Granted for Large-Scale Research Project with IHPS
- Appendix 4E and Audited 2019 Financial Report
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma